BI signs deal with MiNA to develop liver disease drugs
admin 9th November 2017 Uncategorised 0Boehringer Ingelheim has signed a second deal focused on the development of RNA therapeutics for liver diseases.
More: BI signs deal with MiNA to develop liver disease drugs
Source: News